C301-3841 Screening compound: 4-(2-methylpropyl)-N-(2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl)benzene-1-sulfonamide

C301-3841 Screening compound: 4-(2-methylpropyl)-N-(2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl)benzene-1-sulfonamide
C301-3841 Screening compound: 4-(2-methylpropyl)-N-(2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl)benzene-1-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C301-3841
4-(2-methylpropyl)-N-(2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl)benzene-1-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C301-3841

Molecular Formula

C17H19N3O3S (C17 H19 N3 O3 S)

Compound Name

4-(2-methylpropyl)-N-(2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl)benzene-1-sulfonamide

IUPAC name

4-(2-methylpropyl)-N-(2-oxo-23-dihydro-1H-13-benzodiazol-5-yl)benzene-1-sulfonamide

SMILES

CC(C)Cc(cc1)ccc1S(Nc(cc1)cc(N2)c1NC2=O)(=O)=O

InChI

InChI=1S/C17H19N3O3S/c1-11(2)9-12-3-6-14(7-4-12)24(22,23)20-13-5-8-15-16(10-13)19-17(21)18-15/h3-8,10-11,20H,9H2,1-2H3,(H2,18,19,21)

InChI Key

YWXZBLBFABJQIB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD08069903

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

345.42

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.771

Distribution Coefficient, logD

3.727

Water Solubility, LogSw

-4.02

Polar Surface Area

76.615

Acid Dissociation Constant (pKa)

8.37

Base Dissociation Constant (pKb)

3.23

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

23.50

C301-3841 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

Anticancer Library (62698 compounds)

Antimitotic Tubulin Library (17355 compounds)

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Antiviral
  • Infections
  • Immune system

References: we are preparing a list of scientific research reports with C301-3841 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C301-3841?
Check Price and Availability of C301-3841, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C301-3841 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C301-3841
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C301-3841
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C301-3841 available by request